Evidence map›Paper›PMID 28522715›Full record

ArticleGenome announcements2017

Complete Draft Genome Sequence of the Actinobacterium

Bogdan Tokovenko, Christian Rückert, Jörn Kalinowski, Fatemeh Mohammadipanah, Joachim Wink, Birgit Rosenkränzer, Maksym Myronovskyi, Andriy Luzhetskyy

Abstract read
In one paragraph

Article in Genome announcements, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bogdan TokovenkoHelmholtz Institute for Pharmaceutical Research Saarland, Saarbrücken, Germany.
Christian RückertTechnology Platform Genomics, Center for Biotechnology (CeBiTec), Bielefeld University, Bielefeld, Germany.
Jörn KalinowskiTechnology Platform Genomics, Center for Biotechnology (CeBiTec), Bielefeld University, Bielefeld, Germany.
Fatemeh MohammadipanahDepartment of Microbial Biotechnology, School of Biology and Center of Excellence in Phylogeny of Living Organisms, College of Science, University of Tehran, Tehran, Iran fmohammadipanah@ut.ac.ir Andriy.Luzhetskyy@helmholtz-hzi.de.
Joachim WinkMicrobial Strain Collection, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Birgit RosenkränzerUniversity of Saarland, Department of Pharmaceutical Biotechnology, Saarbrücken, Germany.
Maksym MyronovskyiUniversity of Saarland, Department of Pharmaceutical Biotechnology, Saarbrücken, Germany.
Andriy LuzhetskyyHelmholtz Institute for Pharmaceutical Research Saarland, Saarbrücken, Germany fmohammadipanah@ut.ac.ir Andriy.Luzhetskyy@helmholtz-hzi.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The genome sequence of alkalohalophilic actinobacterium

Identifiers

PMID28522715
PMCPMC5477326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.